Nadia Khan, MD

Accepting New Patients
Offers Video Visits
1221 Madison Street, Suite 1020
Seattle, WA 98104
2298.0 miles away
Medical Groups & Affiliations
Swedish
Speaks: English
map

Swedish Cancer Institute Hematologic Malignancies Program

1221 Madison Street, Suite 1020, Seattle, WA 98104

Are you covered?

Check to see if your insurance is covered by this provider.

About Nadia Khan

Dr. Khan is a medical oncologist with expertise in chronic lymphocytic leukemia and lymphomas. She is the Director of the CLL Division here at Swedish Cancer Institute and found her calling in caring for patients with compassion, hand-in-hand with offering cutting edge therapies based on the most recent advances in the field. Dr. Khan’s commitment to providing the latest, most effective and well-tolerated therapies for her patients translates directly to her role in developing clinical trials here at Swedish. A key tenet in her approach to care involves listening to what a patient’s particular needs are. Dr. Khan leads a multi-disciplinary care team here at Swedish, whose aim is to make this challenging experience as easy as possible for patients.

Fellowship

Georgetown University
2013

Internship

Yale New Haven Medical Center
2004

Residency

Temple University
2010

Medical School

Temple University
2003

Board Certifications
  • American Board of Internal Medicine, Hematology
  • American Board of Internal Medicine, Medical Oncology
  • American Board of Internal Medicine, Internal Medicine
Swedish Cancer Institute Hematologic Malignancies Program
1221 Madison Street, Suite 1020
Seattle, WA 98104

Center for Blood Disorders and Stem Cell Transplantation
1221 Madison Street, Floor 10
Seattle, WA 98104

Medical Groups & Affiliations
Swedish

Affiliated Locations
Swedish First Hill

Clinical Interests

  • Blood Cancer
  • Cancer
  • Cancer Chemotherapy
  • Chimeric Antigen Receptor T Cell Therapy
  • Hematologic Malignancies
  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Myelodysplasia
  • Myelodysplastic Syndrome
  • Stem Cell Transplant
  • Stem Cell Transplant For Hematological Malignancy
  • Stem Cell Transplant For Multiple Myeloma